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Introduction
Bisphenol A (BPA) and phthalates are a class 
of synthetic chemicals produced and used 
in large quantities worldwide and present 
in many kind of articles including plastics, 
cosmetics, carpets, building materials, toys, or 
cleaning products (Koch and Calafat 2009). 
In 1999, the European Union banned the 
use of some phthalates in the manufacture 
of toys and childcare articles, and in 2011, 
the use of BPA was banned in infant feeding 
bottles (European Commission 2005, 2011). 
In the United States, environmental and 
public health organizations have conducted 
numerous campaigns to reduce their use in 
consumer products and concentrations in 
the general population of some phthalates 
have started to decline (Zota et al. 2014). 
Diet is the predominant source of BPA and 
high-molecular-weight phthalates (HMWP) 
(Rudel et al. 2011; Wormuth et al. 2006), 
whereas personal care products are the 
major source of the low-molecular-weight 
phthalates (LMWP) (Wormuth et al. 2006). 
Phthalates and BPA have a short biological 
half-life (i.e., few hours or days), but their 
ubiquity implies a constant but highly 
variable exposure (Braun et al. 2012).
BPA and phthalates and their metabolites 
have known endocrine-disrupting proper-
ties that may disrupt hormonal balance 
even at low doses of exposure (Casals-Casas 
and Desvergne 2011). BPA and phthalate 
metabolites can interact with the estrogen, 
androgen, thyroid hormone, glucocorticoid, 
and/or peroxisome proliferator–activated 
receptors (PPARs) that regulate important 
biological processes for the control of adipo-
genesis, insulin levels, fluid retention, and 
bone metabolism (Ahmadian et al. 2013; 
Casals-Casas and Desvergne 2011). Some 
of these hypothesized effects, especially 
those mediated by the steroid hormone 
receptors, could be sex-specific. In animal 
studies, effects of prenatal exposure to BPA 
and phthalate metabolites are controversial, 
with studies reporting a reduction, gain, or 
no effects on body weight (Kim et al. 2001; 
Rubin et al. 2001; Tanaka 2005) and studies 
reporting increased femur length, skeletal 
malformations, or retardation in the ossifi-
cation (Agas et al. 2013; Kim et al. 2001). 
Results from human epidemiological studies 
are also inconsistent (Chou et al. 2011; 
Huang et al. 2014; Lee et al. 2008, 2014; 
Miao et al. 2011; Philippat et al. 2012, 2014; 
Snijder et al. 2013; Suzuki et al. 2010; Wolff 
et al. 2008; Zhang et al. 2009). Most of the 
epidemiological studies have measured child 
anthropometric parameters at birth (Chou 
et al. 2011; Huang et al. 2014; Lee et al. 
2014; Miao et al. 2011; Philippat et al. 2012; 
Suzuki et al. 2010; Wolff et al. 2008; Zhang 
et al. 2009). Only three studies assessed fetal 
growth characteristics associated with prenatal 
BPA exposure (Lee et al. 2008; Philippat 
et al. 2014; Snijder et al. 2013); none did so 
for phthalates. The majority of studies have 
determined BPA and phthalate metabolites 
in urine or blood in one spot sample collected 
during pregnancy; only one study measured 
BPA in more than one urine sample and 
found that the exposure–response relation-
ship became progressively attenuated when 
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Background: Prenatal exposure to bisphenol A (BPA) and phthalates may affect fetal growth; 
however, previous findings are inconsistent and based on few studies.
oBjectives: We assessed whether prenatal exposure to BPA and phthalates was associated with 
fetal growth in a Spanish birth cohort of 488 mother–child pairs.
Methods: We measured BPA and eight phthalates [four di(2-ethylhexyl) phthalate metabolites 
(DEHPm), mono-benzyl phthalate (MBzP), and three low-molecular-weight phthalate metabolites 
(LMWPm)] in two spot-urine samples collected during the first and third trimester of pregnancy. 
We estimated growth curves for femur length (FL), head circumference (HC), abdominal circum-
ference (AC), biparietal diameter (BPD), and estimated fetal weight (EFW) during pregnancy 
(weeks 12–20 and 20–34), and for birth weight, birth length, head circumference at birth, and 
placental weight.
results: Overall, results did not support associations of exposure to BPA or DEHPm during 
pregnancy with fetal growth parameters. Prenatal MBzP exposure was positively associated with 
FL at 20–34 weeks, resulting in an increase of 3.70% of the average FL (95% CI: 0.75, 6.63%) per 
doubling of MBzP concentration. MBzP was positively associated with birth weight among boys 
(48 g; 95% CI: 6, 90) but not in girls (–27 g; 95% CI: –79, 25) (interaction p-value = 0.04). The 
LMWPm mono-n-butyl phthalate (MnBP) was negatively associated with HC at 12–20 pregnancy 
weeks [–4.88% of HC average (95% CI: –8.36, –1.36%)].
conclusions: This study, one of the first to combine repeat exposure biomarker measurements 
and multiple growth measures during pregnancy, finds little evidence of associations of BPA or 
phthalate exposures with fetal growth. Phthalate metabolites MBzP and MnBP were associated 
with some fetal growth parameters, but these findings require replication.
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fewer measurements were available (Snijder 
et al. 2013). This emphasizes the necessity 
of using multiple measurements per subject 
to obtain a more reliable measurement 
of exposure levels. Furthermore, data from 
in vivo studies have revealed sex-dependent 
effects on body weight in rodents exposed 
perinatally to BPA (Rubin and Soto 2009), 
but few human studies have been able to 
evaluate sex-specific effects and findings are 
still controversial (Chou et al. 2011; Huang 
et al. 2014; Lee et al. 2014).
In this study we assessed whether prenatal 
exposure to BPA and phthalates may influ-
ence fetal growth and birth outcomes 
in a Spanish birth cohort of 488 mother–
child pairs.
Methods
Study population.  The INMA study 
(INfancia y Medio Ambiente; Childhood 
and Environment)  i s  a  populat ion-
based birth cohort study that recruited 
657 pregnant women in the Spanish 
region of Sabadell between 2004 and 2006 
(Guxens et al. 2012). Women were recruited 
at their first routine prenatal care visit 
(mean ± SD = 13.4 ± 1.7 weeks of gestation) 
in the primary care center if they fulfilled 
the inclusion criteria: age ≥ 16 years, inten-
tion to deliver in the reference hospital, 
singleton pregnancy, unassisted conception, 
and no communication problems (Guxens 
et al. 2012). The study was approved by the 
Ethics Committee of the reference hospital, 
and all participants gave their written 
informed consent.
Prenatal BPA and phthalate exposure. 
Maternal urine samples were collected 
at 12 ± 1.7 and 32 ± 1.4 weeks of gesta-
tion and stored in polypropylene (for BPA 
analysis) or polyethylene tubes (for phthalate 
metabolites analysis) at –20°C. Total BPA 
(free plus conjugated) was quantified by 
liquid chromatography–mass spectrometry 
in the Department of Analytical Chemistry 
 laboratory– University of Cordoba (Spain) 
(Casas et al. 2013). Eight phthalate metabo-
lites (free plus conjugated) were determined 
by liquid chromatography–mass spectrom-
etry in the Bioanalysis Research Group at the 
Hospital del Mar Medical Research Institute 
(Spain) (Valvi et al. 2015b). Limits of detec-
tion (LODs) for each analyte are listed in 
Table 1. Creatinine was determined at the 
Echevarne laboratory of Barcelona (Spain) by 
the Jaffé method (kinetic with target measure-
ment, compensated method) with Beckman 
Coulter© reactive in AU5400 (IZASA®). All 
BPA and phthalate metabolites concentra-
tions were divided by urinary creatinine 
concentrations to control for urine dilution. 
Selection of women for BPA and phthalates 
measurements was based on criteria set in 
previous studies conducted in this popula-
tion (Casas et al. 2013; Valvi et al. 2015b): 
BPA concentrations were measured in 479 
mothers, whereas phthalate metabolites were 
measured in 391 mothers (see Supplemental 
Material, Figure S1).
Fetal growth and birth outcomes. Routine 
fetal ultrasound examinations, regardless of 
study participation, were scheduled at 12, 20, 
and 34 weeks of pregnancy by obstetricians 
who specialized in conducting this type of 
examinations at the respective hospitals. The 
fetal parameters recorded (millimeters) were 
femur length (FL), head circumference (HC), 
abdominal circumference (AC), and bipari-
etal diameter (BPD). Estimated fetal weight 
(EFW) was calculated using the Hadlock 
algorithm (Hadlock et al. 1985). We had 
access to the records of any other ultrasound 
performed to women in the same hospital unit 
during their pregnancy, including an early 
ultrasound (< 10 weeks of pregnancy). In this 
first ultrasound, crown–rump length (CRL) 
was measured and used to establish gesta-
tional age only when the difference between 
CRL and the self-reported last menstrual 
period was ≥ 7 days. Birth weight (grams) 
was recorded by trainee midwifes at delivery, 
whereas birth length and head circumference 
(both measured in centimeters but expressed 
in millimeters in the present analysis) were 
measured by a nurse when the neonate arrived 
at the hospital ward within the first 12 hr of 
life. We also collected placentas at the time 
of delivery and analyzed placenta weight as 
a measure of growth in utero. Placentas were 
examined and weighed without deciduas 
basalis and chorionic plate. In our analysis 
we included women with at least two ultra-
sound measurements conducted at any time 
during pregnancy and with at least one birth 
outcome available at the time of delivery (see 
Supplemental Material, Figure S1).
Linear mixed models were used to obtain 
longitudinal growth curves for the five fetal 
parameters (see Supplemental Material, 
Figure S2). A detailed description of these 
growth curves is provided by Iñiguez et al. 
(2015). To obtain an individualized rather 
than a population-based growth standard, 
we tested physiological factors known to 
affect fetal growth (Mamelle et al. 2006) and 
their interactions with gestational age in days 
using the likelihood ratio (LR) test (p < 0.05) 
through a forward selection procedure. These 
physiological factors included maternal age, 




% < LOD  
(1st–3rd trimester) GM (95% CI)
Minimum–
maximum ICCb (95% CI)
Creatinine (g/L)
1st trimester 488 0.82 (0.78, 0.86) 0.1–2.7 0.22 (0.14, 0.31)
3rd trimester 488 0.88 (0.83, 0.92) 0.1–3.0
Unadjusted (μg/L)
BPA 470 0.1 0–0.6 2.3 (2.1, 2.4) 0.3–61.8 0.15 (0.06, 0.24)
Phthalates 
ΣDEHPm 390 92.5 (86.5, 99.1) 14.3–1428.9
MEHP 390 1 0.5–0.8 9.6 (9.0, 10.3) 1.3–202.0 0.20 (0.10, 0.29)
MEHHP 390 0.5 0 25.5 (23.6, 27.5) 3.2–536.0 0.08 (0.00, 0.18)
MEOHP 390 0.5 0 19.0 (17.7, 20.4) 2.3–342.8 0.08 (0.00, 0.18)
MECPP 390 1 0–0.3 36.2 (33.7, 38.9) 4.6–476.1
MBzP 390 0.5 0.8 11.1 (10.2, 12.1) 0.8–336.4 0.22 (0.12, 0.31)
ΣLMWPm 390 428.7 (392.9, 467.8) 43.1–5183.1
MEP 390 1 0–0.3 335.6 (303.4, 371.3) 21.9–5115.1 0.23 (0.14, 0.33)
MiBP 390 0.5 0 28.8 (26.7, 31.0) 4.0–367.6 0.22 (0.13, 0.32)
MnBP 390 1 0.8 29.0 (26.7, 31.5) 3.4–402.6 0.20 (0.10, 0.29)
Creatinine-adjusted (μg/g)
BPA 470 0.1 0–0.6 2.6 (2.4, 2.8) 0.3–69.4 0.14 (0.05, 0.22)
Phthalates 
ΣDEHPm 390 106.1 (99.8, 112.8) 26.5–1670.0
MEHP 390 1 0.5–0.8 11.3 (10.6, 12.1) 1.8–266.9 0.18 (0.08, 0.28)
MEHHP 390 0.5 0 29.0 (27.1, 31.0) 5.3–503.4 0.06 (0.00, 0.16)
MEOHP 390 0.5 0 21.7 (20.3, 23.1) 4.1–378.3 0.06 (0.00, 0.16)
MECPP 390 1 0–0.3 41.4 (38.9, 44.1) 7.7–718.9 0.19 (0.09, 0.29)
MBzP 390 0.5 0.8 12.6 (11.6, 13.6) 1.5–405.1 0.23 (0.14, 0.33)
ΣLMWPm 390 494.8 (456.2, 536.7) 65.2–10030.2
MEP 390 1 0–0.3 389.1 (353.4, 428.4) 34.0–9379.8 0.23 (0.13, 0.32)
MiBP 390 0.5 0 33.0 (31.0, 35.1) 5.1–334.2 0.19 (0.09, 0.29)
MnBP 390 1 0.8 32.7 (30.4, 35.2) 5.8–835.7 0.19 (0.09, 0.29)
Abbreviations: BPA, bisphenol A; CI, confidence interval; DEHPm, di-2-ethylhexyl phthalate metabolites; GM, geometric 
mean; ICC, intraclass correlation coefficient; LMWPm, low molecular weight phthalate metabolites; LOD, limit of 
detection; MBzP, mono-benzyl phthalate; MECPP, mono(2-ethyl-5-carboxy-pentyl) phthalate; MEHHP, mono(2-ethyl-5-
hydroxy-hexyl) phthalate; MEHP, mono(2-ethyl-hexyl) phthalate; MEOHP, mono(2-ethyl-5-oxo-hexyl) phthalate; MEP, 
mono-ethyl phthalate; MiBP, mono-isobutyl phthalate; MnBP, mono-n-butyl phthalate.
aAverage of measurements at two time points in the first and third trimesters of pregnancy. bThe ICC is calculated by 
dividing the between-person variability by the sum of the between- and within-person variability. Values range from 0 
(i.e., no reproducibility of the same measurement within a subject) to 1 (i.e., perfect reproducibility).
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parity, country of origin, maternal height, 
maternal prepregnancy weight or body mass 
index (BMI), paternal height, weight or BMI, 
and child sex. Only the significant ones were 
included in the models (see Supplemental 
Material, Table S1). Growth models were 
then applied to calculated standard devia-
tion (SD) scores at 12, 20, and 34 weeks of 
gestation, representing cross-sectional esti-
mates of fetal size (e.g., size at 12 weeks), and 
SD scores over the week intervals 12–20 and 
20–34, representing fetal growth between 
two periods (e.g., growth between 12 and 
20 weeks) (Gurrin et al. 2001). Growth 
curves were generated by using R software (R 
Core Team 2013). Because birth outcomes 
depend largely on the gestational age, growth 
curves for birth weight, length, head circum-
ference, and placental weight were fitted to 
further standardize them to week 40 of gesta-
tion using the Box–Cox power exponential 
method (Rigby and Stasinopoulos 2004) and 
adjusting by sex.
Covariates. Information on maternal 
age, education, social class, country of origin, 
weight and height, parity, health history, 
marital status, dietary intake, use of house-
hold cleaning products, active smoking, 
time of urine collection, and season of birth 
was obtained by self-reported question-
naires administrated by trained interviewers 
at weeks 12 and 32 of pregnancy. Child sex 
was obtained from clinical records. Cotinine 
was determined in urine at 32 pregnancy 
weeks, using commercial competitive enzyme 
immunoassay microplate test kits (OraSure 
Technologies Inc., Bio-Rad) with a limit of 
quantification (LOQ) of 4.0 μg/L.
Statistical analysis. Urinary concentrations 
of BPA and phthalate metabolites below the 
LOD were assigned a value of half the LOD. 
Reproducibility of urinary BPA and phthalate 
metabolites between the first and third trimes-
ters was obtained by calculating the intraclass 
correlation coefficient (ICC) using random 
one-way intercept linear mixed models. We 
also calculated Pearson correlations of the 
log-transformed compounds concentrations. 
Because of the short biological half-lives of 
these compounds (Koch and Calafat 2009), 
we used the average of the creatinine-adjusted 
concentrations determined in 12 and 32 weeks 
of pregnancy to provide a better estimation 
of exposure during pregnancy. Because of 
the approximate log-normal distribution of 
urinary concentrations, average creatinine-
adjusted concentrations of pollutants were 
log2-transformed.
Generalized additive models were used to 
evaluate linearity of our exposure–outcome 
relationships. Associations between BPA/
phthalates and SD scores for fetal size/growth, 
and birth parameters were then examined by 
univariate and multivariate linear regression 
models. To determine the covariates included 
in the multivariate models, we applied 
directed acyclic graphs (DAGs) (Shrier and 
Platt 2008). Covariates were included in the 
DAGs if they were described to be associated 
with the exposure or the outcome in previous 
literature (Aguilera et al. 2010; Casas et al. 
2013; Snijder et al. 2013; Valvi et al. 2013), 
and such associations were shown in bivar-
iate analyses of our data (see Supplemental 
Material, Table S2) (p ≤ 0.1). Based on the 
DAGs, the final multivariate models were 
adjusted for maternal education (primary, 
secondary, university), smoking during preg-
nancy (never smoked, not during pregnancy, 
during pregnancy), and parity (nulliparous, 
multiparous). Departing from this multivariate 
model, we then conducted a forward stepwise 
selection procedure including other potential 
confounders and ancestors and testing if they 
changed the coefficient by > 10%: birth season, 
urinary cotinine levels during pregnancy, 
consumption of canned fish during pregnancy, 
time of urine collection, and use of house-
hold cleaning products. Birth season (winter, 
spring, summer, autumn) and urinary cotinine 
levels during pregnancy [non–secondhand 
tobacco smoke (SHS) exposure, < 18 ng/mL; 
SHS exposed, 18–50 ng/mL; active smoker, 
> 50 ng/mL] changed most of the coefficients 
by > 10% and hence they were included in 
all final models. Because fetal HC growth 
models were already adjusted for parity (see 
Supplemental Material, Table S1), this variable 
was not included in the fetal HC multivariate 
models. Finally, newborn’s HC models were 
also adjusted for type of delivery (vaginal, 
instrumental, cesarean) because passage 
through the birth canal may influence HC 
at birth. We are only presenting the adjusted 
models because they yielded results similar to 
the unadjusted ones.
Results for phthalates are presented 
for the sum (micrograms per liter) of the 
four DEHP [di(2-ethylhexyl) phthalate] 
metabolites {∑DEHPm: MEHP [mono(2-
ethylhexyl) phthalate], MEHHP [mono(2-
ethyl-5-hydroxyhexyl) phthalate], MEOHP 
[mono(2-ethyl-5-oxohexyl) phthalate], and 
MECPP [mono(2-ethyl-5-carboxypentyl) 
Figure 1. Adjusted associations between maternal urinary BPA levels (μg/g creatinine) and fetal size 
and growth parameters in the overall population, in girls, and in boys: femur length (A), head circumfer-
ence (B), abdominal circumference (C), and estimated fetal weight (D). 
BPA, bisphenol A. Mean percent difference in standard deviation scores per doubling of BPA levels (levels were log2-
transformed). Femur length model was adjusted for maternal age, maternal height, paternal weight, maternal country of 
origin, maternal education, smoking during pregnancy, parity, birth season, and urinary cotinine levels during pregnancy. 
Head circumference model was adjusted for maternal age, maternal height/weight, paternal weight, maternal education, 
smoking during pregnancy, parity, birth season, and urinary cotinine levels during pregnancy. Abdominal circumference 
model was adjusted for maternal age, maternal height/weight, paternal weight, maternal country of origin, maternal 
education, smoking during pregnancy, parity, birth season, and urinary cotinine levels during pregnancy. Estimated fetal 
weight model was adjusted for maternal age, maternal height, paternal weight, maternal country of origin, maternal edu-
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phthalate]}, MBzP (monobenzyl phthalate), 
the sum (micrograms per liter) of the three 
LMWP metabolites [∑LMWPm: MEP 
(monoethyl phthalate), MiBP (monoiso-
butyl phthalate), and MnBP (mono-n-butyl 
phthalate)], and for each single phthalate 
metabolite. Because these parent and metabo-
lites compounds are hormonally active, we 
report all primary analyses stratified by sex, 
in addition to reporting estimated for boys 
and girls combined. We performed likelihood 
ratio tests of interaction terms for exposure 
and sex to identify significant modification by 
sex based on p ≤ 0.1. To evaluate the robust-
ness of our results, we conducted various 
sensitivity analyses and considered whether the 
findings were generally consistent throughout 
the different models. First, we repeated 
the models adjusting for urinary creatinine 
concentrations as has been performed in other 
studies (Philippat et al. 2012). Second, we 
also repeated the analyses excluding extreme 
values of creatinine that ranged between 
< 0.3 g/L and > 3.0 g/L (n = 40) to prevent 
“dilution effects” in the urine samples (Aitio 
1996). Third, we performed multi-pollutant 
models where the four main exposure variables 
were included (BPA, ∑DEHPm, MBzP, and 
∑LMWPm) and evaluated whether coeffi-
cient changed by comparing results with the 
single-pollutant model after restricting the 
data to observations with complete data for 
all four pollutants. All statistical analyses were 
conducted with Stata 12.0 statistical software 
(StataCorp, College Station, TX, USA).
Results
Study population and exposure characteris-
tics. Of the 657 pregnant women initially 
enrolled, 488 mother–child pairs had infor-
mation on prenatal BPA (n = 470) and/
or phthalate metabolites concentrations 
(n = 390) and fetal growth parameters or 
birth outcomes (see Supplemental Material, 
Figure S1). Women included in the study 
were more likely to be Spanish, well-
educated, and from a higher socioeconomic 
position than INMA-Sabadell participants 
not included in the analysis (data not shown). 
Complete details of the characteristics of the 
study population are given in Supplemental 
Material, Table S2.
BPA and phthalate metabolites were 
detected in most of the urine samples 
(0–0.8% < LOD) (Table 1). The unadjusted 
geometric mean (GM) BPA concentration 
was 2.3 μg/L [95% confidence interval (CI): 
2.1, 2.4]. Among phthalate metabolites, 
the low molecular weight phthalate MEP 
presented the highest concentration (GM: 
335.6 μg/L; 95% CI: 303.4, 371.3), whereas 
MEHP and MBzP showed the lowest (GM: 
9.6 μg/L; 95% CI: 9.0, 10.3; GM: 11.1 μg/L; 
95% CI: 10.2, 12.1, respectively). The ICCs 
comparing samples collected in the first and 
third trimesters ranged from 0.06 to 0.23, 
with the highest ICC for MBzP and MEP 
and the lowest for MEHHP and MEOHP 
(Table 1). Low correlations were found 
between the different exposure groups (BPA, 
ΣDEHPm, MBzP, and ΣLMWPm), with 
Pearson correlation coefficients ranging from 
0.14 to 0.32 (see Supplemental Material, 
Table S3). A total of 1,452 ultrasound exami-
nations were performed for the 488 pregnan-
cies. Most women (n = 473) had one routine 
ultrasound examination in each trimester 
of pregnancy but 15 (3%) women had 
four to six examinations. The mean (± SD) 
gestational age, birth and placental weight 
were 39.7 ± 1.4 weeks, 3,319 ± 391 g, and 
602 ± 110 g, respectively (data not shown).
BPA and fetal growth and birth outcomes. 
Exposure to BPA during pregnancy was 
negatively associated with FL and EFW 
from 12 to 20 weeks resulting in a percent 
reduction in SD scores of –4.26% (95% CI: 
–7.91, –0.65%) and –3.84% (95% CI: 
–7.93, 0.30%), respectively, for each doubling 
of concentration of maternal urinary BPA 
(Figure 1). Negative associations of BPA 
with growth in FL and EFW from 12 to 
20 weeks were evident in boys but not in girls 
(e.g., for growth in EFW, –5.74%; 95% CI: 
–11.08, –0.29% and –0.98%; 95% CI: 
–7.35, 5.42% in boys and girls, respectively), 
but the differences between boys and girls 
were not significant (p interaction = 0.22 for 
FL, p = 0.15 for EFW) (Figure 1). Significant 
differences by sex in EFW at 12 weeks and 
20 weeks were due to a significant positive 
association with size at 12 weeks in girls and a 
null association in boys (p interaction = 0.05), 
whereas at 20 weeks there was a weak positive 
association with EFW in girls and a stronger 
nonsignificant negative association in boys 
Table 2. Adjusted associations between maternal urinary BPA and phthalate metabolites levels (μg/g creatinine) and birth outcomes in the overall population, in 
girls, and in boys.
Compounds
Overall Girls Boys
p Interactionn β (95% CI) n β (95% CI) n β (95% CI)
BPA
Weight (g) 448 –16.24 (–54.10, 21.62) 219 –21.56 (–82.93, 39.82) 229 –11.01 (–57.39, 35.37) 0.99
Placental weight (g) 398 0.53 (–10.79, 11.86) 193 –8.01 (–28.03, 12.01) 205 6.98 (–6.47, 20.44) 0.28
Length (mm) 441 –0.37 (–2.00, 1.25) 212 –0.64 (–3.21, 1.93) 229 –0.27 (–2.31, 1.77) 0.93
Head circumference (mm) 435 0.47 (–0.66, 1.60) 208 0.38 (–1.47, 2.23) 227 0.54 (–0.77, 1.85) 0.77
Gestational age (weeks) 453 1.19 (–0.19, 2.58) 220 1.65 (–0.56, 0.39) 233 0.63 (–1.21, 2.46) 0.54
ΣDEHPm
Weight (g) 371 15.56 (–28.75, 59.87) 179 5.92 (–60.59, 72.42) 192 14.68 (–44.11, 73.48) 0.82
Placental weight (g) 325 1.31 (–12.30, 14.93) 154 –14.25 (–36.73, 8.24) 171 13.94 (–2.85, 30.72) 0.04
Length (mm) 364 0.38 (–1.59, 2.35) 172 0.78 (–2.06, 3.61) 192 –0.25 (–2.91, 2.40) 0.84
Head circumference (mm) 359 0.16 (–1.15, 1.47) 169 0.00 (–1.98, 1.97) 190 0.17 (–1.46, 1.80) 0.56
Gestational age (weeks) 375 –0.13 (–1.72, 1.46) 180 0.20 (–2.23, 2.63) 195 –0.48 (–2.65, 1.69) 0.71
MBzP
Weight (g) 371 14.11 (–19.08, 47.29) 179 –27.30 (–79.41, 24.80) 192 47.78 (5.78, 89.78) 0.04
Placental weight (g) 325 0.75 (–9.79, 11.30) 154 –20.57 (–39.22, –1.92) 171 12.53 (0.27, 24.79) 0.02
Length (mm) 364 –0.42 (–1.90, 1.07) 172 –1.42 (–3.67, 0.84) 192 0.43 (–1.49, 2.35) 0.24
Head circumference (mm) 359 –0.07 (–1.05, 0.92) 169 –0.92 (–2.47, 0.62) 190 0.70 (–0.48, 1.88) 0.07
Gestational age (weeks) 375 –0.39 (–1.61, 0.83) 180 –0.43 (–2.34, 1.48) 195 –0.43 (–2.06, 1.20) 0.97
ΣLMWPm
Weight (g) 371 –10.02 (–42.84, 22.80) 179 –11.55 (–62.08, 38.97) 192 6.16 (–37.64, 49.95) 0.47
Placental weight (g) 325 4.20 (–6.05, 14.46) 154 –1.65 (–19.31, 16.01) 171 9.18 (–3.42, 21.78) 0.18
Length (mm) 364 –0.74 (–2.20, 0.72) 172 –0.24 (–2.39, 1.92) 192 –0.77 (–2.75, 1.20) 0.97
Head circumference (mm) 359 –0.54 (–1.51, 0.43) 169 –0.13 (–1.62, 1.36) 190 –0.62 (–1.85, 0.61) 0.89
Gestational age (weeks) 375 0.27 (–0.94, 1.48) 180 0.38 (–1.48, 2.24) 195 –0.29 (–1.96, 1.39) 0.42
Abbreviations: BPA, bisphenol A; CI, confidence interval; DEHPm, di(2-ethylhexyl) phthalate metabolites; MBzP, mono-benzyl phthalate; LMWPm, low-molecular-weight phthalate 
metabolites. Betas represent the estimated difference in each outcome associated per doubling of exposure levels (levels were log2-transformed). All models were adjusted for 
maternal education, smoking during pregnancy, parity, birth season, and urinary cotinine levels during pregnancy. Head circumference models also adjusted for type of delivery.
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(p interaction = 0.05) (Figure 1). There was 
also a significant difference by sex in the asso-
ciation of BPA with AC at 12 weeks, with a 
positive association among girls (6.41%; 
95% CI: 1.16, 11.54%) and no association 
among boys (–0.75%; 95% CI: –5.35, 3.87%) 
(p interaction = 0.03) (Figure 1). Prenatal BPA 
exposure was not significantly associated with 
any of the birth outcomes studied, though 
there was a small and nonsignificant associa-
tion with gestational age at birth (1.19 weeks 
per doubling of BPA concentration; 95% CI: 
–0.19, 2.58) (Table 2). None of the associa-
tions that were statistically significant for BPA 
in the main analysis (for FL and EFW growth 
from 12 to 20 weeks, and for EFW and AC 
at 12 weeks in girls) were statistically signifi-
cant in all the sensitivity analyses related to 
creatinine (i.e., adjusted for creatinine or after 
excluding samples with extreme creatinine 
values) (see Supplemental Material Table S4). 
The inclusion of all four main exposures in one 
multi-pollutant model led to changes in coef-
ficients between 5 and 80% compared with 
results with the single-pollutant model (see 
Supplemental Material, Table S5).
Phthalate metabolites and fetal growth and 
birth outcomes. Exposure to ∑DEHPm and its 
single metabolites during pregnancy was not 
significantly associated with any of the fetal 
growth (see Supplemental Material, Table S6) 
or birth outcomes assessed (Table 2; see also 
Supplemental Material, Table S7). A doubling 
of prenatal MBzP exposure was associated with 
a 3.70% increase (95% CI: 0.75, 6.63%) in 
FL growth from 20 to 34 weeks (Figure 2; see 
also Supplemental Material, Table S8). Among 
girls a doubling of MBzP was associated 
with a 6.12% higher FL growth from 20 to 
34 weeks (95% CI: 1.61, 10.55%) compared 
with 2.10% (95% CI: –1.86, 6.04%) in boys, 
though the difference was not significant 
(p interaction = 0.15) (Figure 2). At birth, a 
doubling of MBzP was associated with higher 
birth weight in boys (48 g; 95% CI: 6, 90) 
but not in girls (–27 g; 95% CI: –79, 25) 
(p interaction = 0.04), and was positively 
associated with placental weight in boys (13 g; 
95% CI = 0.3, 25) but negatively associated 
in girls (–21 g; 95% CI: –39, –2) (p inter-
action = 0.02) (Table 2). After conducting 
various sensitivity analyses related to creati-
nine (i.e., adjusted for creatinine, excluding 
creatinine extreme values) the association 
between MBzP and placental weight in 
girls and boys was not statistically signifi-
cant (see Supplemental Material, Table S4). 
Associations between MzBP and FL and birth 
weight were consistent after including the four 
main exposure variables (see Supplemental 
Material, Table S5).
Exposure  to  ∑LMWPm was  not 
significantly associated with any of the 
fetal size or fetal growth outcomes (see 
Supplemental Material, Table S8) or any 
of the birth outcomes assessed (Table 2; 
see also Supplemental Material, Table S7). 
The metabolite MnBP was associated with 
significantly lower HC growth from 12 to 
20 weeks (–4.88%; 95% CI: –8.36, –1.36%) 
and EFW growth from 12 to 20 weeks 
(–4.32%; 95% CI: –8.33, –0.27%) (Figure 3; 
see also Supplemental Material, Table S8). 
MnBP was associated with greater AC and 
EFW growth from 20 to 34 weeks in boys 
(4.29%; 95% CI: 0.01, 8.53% and 4.27%; 
95% CI: –0.18, 8.68%, respectively) but 
not in girls (0.39%; 95% CI: –4.76, 5.54% 
and 1.22%; 95% CI: –3.36, 5.78%, respec-
tively), though differences were not significant 
(p interaction = 0.21 and 0.31, respectively) 
(Figure 3). MnBP was also associated with 
higher birth weight in boys (57 g; 95% CI: 
3, 110) but not girls (11 g; 95% CI: –40, 62) 
(p interaction = 0.29) (see Supplemental 
Material, Table S7). Further, the metabo-
lite MiBP was associated with lower birth 
weight in girls (–73 g; 95% CI: –137, –9) 
but not among boys (19 g; 95% CI: –35, 74) 
(p interaction = 0.08) (see Supplemental 
Material, Table S6). Associations of indi-
vidual LMWP metabolites with other birth 
outcomes were not statistically significant 
overall or in girls or boys (see Supplemental 
Material, Table S7). Of the associations 
that were statistically significant in primary 
analyses, only the association between MnBP 
and HC growth from 12 to 20 weeks met 
our criteria for consistency (see Supplemental 
Material, Tables S4 and S5).
Discussion
In this population of pregnant women with 
a common exposure to BPA and phthal-
ates, we found few associations between 
these compounds and fetal growth and 
birth outcomes. The HMWPm MBzP was 
significantly associated with greater FL 
growth from 20 to 34 weeks in the overall 
population and with significantly higher birth 
weight in boys, but not in girls. In contrast, 
the LMWPm MnBP was associated with 
lower HC growth from 12 to 20 weeks in 
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Figure 2. Adjusted associations between maternal urinary MBzP levels (μg/g creatinine) and fetal size 
and growth parameters in the overall population, in girls, and in boys: femur length (A), head circumfer-
ence (B), abdominal circumference (C), and estimated fetal weight (D).
MBzP, mono-benzyl phthalate. Mean percent difference in standard deviation scores per doubling of MBzP levels (levels 
were log2-transformed). Femur length model was adjusted for maternal age, maternal height, paternal weight, maternal 
country of origin, maternal education, smoking during pregnancy, parity, birth season, and urinary cotinine levels during 
pregnancy. Head circumference model was adjusted for maternal age, maternal height/weight, paternal weight, maternal 
education, smoking during pregnancy, parity, birth season, and urinary cotinine levels during pregnancy. Abdominal 
circumference model was adjusted for maternal age, maternal height/weight, paternal weight, maternal country of ori-
gin, maternal education, smoking during pregnancy, parity, birth season, and urinary cotinine levels during pregnancy. 
Estimated fetal weight model was adjusted for maternal age, maternal height, paternal weight, maternal country of origin, 
maternal education, smoking during pregnancy, parity, birth season, and urinary cotinine levels during pregnancy. *p 
interaction for sex ≤ 0.1. 
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sex differences. These associations persisted 
after sensitivity analyses, including adjust-
ment for other pollutants. Maternal urinary 
BPA and DEHPm concentrations were not 
significantly associated with any of the growth 
outcomes assessed either during fetal life 
or at birth.
Concentrations of BPA among pregnant 
women in our population were similar to 
populations in other studies where BPA and 
fetal growth outcomes were evaluated (Lee 
et al. 2008; Philippat et al. 2014; Snijder et al. 
2013). In two of these studies, high prenatal 
BPA concentrations were associated with 
reduced fetal growth; but the sample size was 
relatively small [n = 125 in Lee et al. (2008); 
n = 80 in Snijder et al. (2013)]. Also, they did 
not assess either sex-specific differences or the 
influence of other pollutants. In the EDEN 
cohort study, which included only boys, no 
associations were observed between BPA and 
fetal growth (Philippat et al. 2014). In our 
population, although we found statistically 
significant sex-specific associations between 
prenatal BPA exposure and FL, AC, and EFW, 
these associations did not meet our criteria 
for robustness in sensitivity analyses. We also 
did not find significant associations between 
BPA and any of the anthropometric measures 
at birth. Epidemiological studies assessing 
birth outcomes have also shown contradic-
tory results, with some studies showing an 
increase in anthropometric measures (Lee 
et al. 2014; Philippat et al. 2012), and others 
finding a decrease (Chou et al. 2011; Miao 
et al. 2011), or null associations (Wolff et al. 
2008). In animal studies discrepant results also 
exist regarding BPA effects on fetal weight gain 
and bone development (Agas et al. 2013; Kim 
et al. 2001; Somm et al. 2009). It is worth 
noting that prenatal BPA exposure was posi-
tively associated with waist circumference and 
BMI at 4 years in the same INMA-Sabadell 
birth cohort, but not at earlier ages (Valvi et al. 
2013). Thus, whether prenatal exposure to 
BPA may start affecting fetal growth during 
pregnancy but with effects to be observed 
only at later ages needs to be further explored 
(Unüvar and Büyükgebiz 2012).
Phthalate metabolite levels in urine of 
pregnant women from our population were of 
similar magnitude to those reported in other 
studies assessing phthalates in relation to birth 
outcomes (Philippat et al. 2012; Suzuki et al. 
2010; Wolff et al. 2008). Two other studies 
measured the parent and not the metabo-
lite phthalate compounds in blood, so the 
comparison of levels with those of the present 
study is difficult (Huang et al. 2014; Zhang 
et al. 2009). Again, inconsistent results were 
found between studies, with one showing an 
increase in length and head circumference 
at birth (Wolff et al. 2008); some showing 
a decrease in birth weight, length, and head 
circumference among other growth param-
eters (Huang et al. 2014; Zhang et al. 2009); 
and others reporting no associations with any 
phthalates exposure (Philippat et al. 2012; 
Suzuki et al. 2010). To our knowledge, 
no study thus far has evaluated ultrasound 
measurements in relation to phthalates 
exposure during pregnancy. We found that 
prenatal exposure to the HMW phthalate 
MBzP was positively associated with fetal FL 
growth from 20 to 34 weeks in the overall 
population and with higher birth weight in 
boys but not among girls. Our results are in 
line with toxicological and animal studies 
suggesting that exposure to MBzP or its 
parent compound benzyl butyl phthalate 
(BBP) may stimulate adipogenesis and 
increase osteoblast proliferation (Agas et al. 
2013; Hurst and Waxman 2003). On the 
contrary, exposure to the LMWPm MnBP 
seemed to be associated with a decrease in 
fetal HC early in pregnancy. Huang et al. 
(2014) observed a reduction in HC and in 
other fetal parameters at birth associated 
with exposure to dibutyl phthalate (DBP), 
the precursor of MnBP. Zhang et al. (2009) 
assessed birth weight and found an increased 
risk of low birth weight associated with DBP 
exposure; however, both of these studies 
measured phthalates exposure in blood 
samples, which may not produce reliable 
estimates of exposure. In rodents, decreased 
growth was also observed after exposure to 
DBP (Marsman 1995). In the INMA-
Sabadell birth cohort, boys presented reduced 
weight gain and reduced risk of overweight 
from birth until 7 years of age linked to a 
high HMWPm exposure during pregnancy; 
no associations were found for LMWPm 
(Valvi et al. 2015a). Children with higher 
weight at birth compared with children with 
lower birth weights may tend to grow more 
slowly during the first years of life, and they 
could be at lower risk of obesity later in child-
hood and adult life (Labayen et al. 2012). 
More studies are needed to disentangle the 
potential effects of exposure to phthalates 
during pregnancy on fetus and child growth.
This study has some limitations. First, 
although we used the average of two BPA and 
Figure 3. Adjusted associations between maternal urinary MnBP levels (μg/g creatinine) and fetal and 
size growth parameters in the overall population, in girls, and in boys: femur length (A), head circumfer-
ence (B), abdominal circumference (C), and estimated fetal weight (D).
MnBP, mono-n-butyl phthalate. Mean percent difference in standard deviation scores per doubling of MnBP levels 
(levels were log2-transformed). Femur length model was adjusted for maternal age, maternal height, paternal weight, 
maternal country of origin, maternal education, smoking during pregnancy, parity, birth season, and urinary cotinine 
levels during pregnancy. Head circumference model was adjusted for maternal age, maternal height/weight, paternal 
weight, maternal education, smoking during pregnancy, parity, birth season, and urinary cotinine levels during 
pregnancy. Abdominal circumference model was adjusted for maternal age, maternal height/weight, paternal weight, 
maternal country of origin, maternal education, smoking during pregnancy, parity, birth season, and urinary cotinine 
levels during pregnancy. Estimated fetal weight model was adjusted for maternal age, maternal height, paternal weight, 
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phthalate measurements during pregnancy, 
the high within-person and within- and 
between-day variability of these compounds 
means that exposure misclassification cannot 
be ruled out. Such misclassification is likely to 
be random with respect to our outcomes, and 
is thus most likely to have led to an attenu-
ation of associations (Pollack et al. 2013). 
Second, we were able to include BPA and 
phthalate exposures in one model, and we 
showed that those more strongly associated to 
fetal growth and birth outcomes were MBzP 
and MnBP. Third, because of the small 
number of ultrasounds performed from week 
35 onward, we could not assess the influence 
of BPA and phthalates on fetal growth during 
late pregnancy (i.e., weeks 35–38), when 
most of the constitutional variation in fetal 
parameters occur (Hindmarsh et al. 2002). 
Fourth, INMA-Sabadell cohort participants 
included in the analysis were more likely to 
be Spanish, more educated, and from a higher 
socioeconomic class than those excluded 
from the analysis. Lower education and lower 
socioeconomic class are linked to higher 
urine concentrations of BPA and phthalates 
in our population (Casas et al. 2013; Valvi 
et al. 2015b) and to higher risk of adverse 
pregnancy outcomes (de Graaf et al. 2013); 
thus, the most highly exposed and most 
susceptible women could have been excluded 
from analysis. Finally, we performed quite a 
large number of comparisons between expo-
sures and outcomes, which may have led to 
spurious findings.
The major strength of this paper relies on 
its prospective design and the use of repeated 
measurements of fetal biometry. Also, we 
had repeated measurements of BPA and 
phthalates at the first and third trimester of 
pregnancy in almost 500 pregnant women, 
making this, to our knowledge, the largest 
and most extensive study on this topic. 
Finally, we had data available for a large 
number of potential confounders.
Conclusions
This study is one of the first to combine 
repeat exposure biomarker measurements 
and multiple growth measures during preg-
nancy. We did not find consistent or strong 
evidence of associations between BPA or 
phthalate exposures and fetal growth, though 
the phthalate metabolites MBzP and MnBP 
were associated with some fetal growth 
parameters. These findings require replica-
tion. Production of some phthalates and BPA 
has already been banned in some countries 
and replaced by other chemicals such as the 
BPA analogs BPE or BPF that can also have 
endocrine-disrupting activity (Rosenmai et al. 
2014). Investigating the effects of phthalates 
and BPA is relevant for improving current 
knowledge of health effects in children and 
provides further guidelines for an effective 
regulatory policy, given that they have similar 
structure and mechanisms of action.
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